Utrecht / Leeuwarden / Groningen / Haarlem / Hertogenbosch / Helsinki / Heerhugowaard / Washington / DC / The Hague / Assen / Meppel / /
Company
Montgomery SA / Moher D. CONSORT Group / Arkel Group / Creative Commons / Clinical Psychiatry / Altman DG / EuroQol Group / Google / /
Country
Netherlands / /
Currency
pence / / /
Event
FDA Phase / Product Issues / /
Facility
Clinical Pharmacy / Parnassia Psychiatric Institute / VU University / Jeroen Bosch Hospital / University Center / University of Groningen / Wilhelmina Hospital / Groningen Institute of Pharmacy / Institute of Pharmacy / University Medical Center Groningen / Diaconessen Hospital / University School / /
IndustryTerm
treatment of depression / study protocol / pharmacy interaction monitoring software / online publication / online submission / /
MedicalCondition
Semla T. Depression / depressive disorders / major depressive disorder / late life depression / Background Depressive disorder / mental diseases / chronic major depression / Dutch Guideline Depression / very disabling disease / MS / Mental Disorders / psychiatric diseases / disease / Psychiatric Illness / anxiety disorders / psychiatric disorders / chronic disease / diseases / depression / physical diseases / injuries / /
MedicalTreatment
pharmacotherapy / /
Organization
Groningen Institute of Pharmacy / American Geriatrics Society / 2Groningen Institute of Pharmacy / Royal Dutch Pharmacist Association / Independent Ethics Committee / Unit of Pharmacoepidemiology & Pharmacoeconomics / VU University / Amsterdam / Laboratory for Drug Analysis & Toxicology / Department of Geriatric Medicine and Expertise Centere Pharmacotherapy / American Psychiatric Association / Department of Clinical Pharmacy and Pharmacology / Netherlands Organization for Health Research and Development / Parnassia Psychiatric Institute / Jeroen Bosch Hospital / Unit of Pharmacotherapy & Pharmaceutical Care / University Center for Psychiatry / Diaconessen Hospital / Indiana University School of Medicine / Copeland JR / University of Groningen / /
Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)